Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹347 Cr₹317 Cr₹261 Cr₹237 Cr₹60 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹347 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹347 Cr
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹347 Cr
9.22
Mar2025 ₹317 Cr
21.53
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,410.8 Cr -4.6% 9% 21.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,299.0 Cr 1% 7.5% 7.9% Stock Analytics
DIVIS LABORATORIES ₹297,325.0 Cr 0.8% 22.8% 71.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,727.0 Cr 0.2% 1.9% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹116,145.0 Cr 0.8% 12.2% 12.3% Stock Analytics
CIPLA ₹114,312.0 Cr 1.5% 6.4% -7.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-4.6%

9%

21.5%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses